Business
Longeviti Neuro Solutions Appoints T. Rowe Price CEO Robert W. Sharps to Board of Directors
--Veteran global investment leader joins neurotechnology company advancing AI-enabled brain health platforms--BALTIMORE, March 20, 2026 (GLOBE NEWSWIRE) -- Longeviti Neuro Solutions, a neurotechnology company developing advanced implantable and AI-enabled solutions for neurological health including the ClearFit AI™, the first Acoustic Brain Interface (ABI)™, today announced the appointment of Robert W. Sharps, Chief Executive Officer and President of T. Rowe Price Group, Inc. (NASDAQ: TROW), to
About this update from T. Rowe Price Group, Inc.
[{"type":"image","alt":"Longeviti Neuro Solutions","displaySize":"","headline":null,"caption":"Longeviti Neuro Solutions","className":"","disableSlideshowImg":false,"size":{"original":{"width":212,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/ec2fc080a7b8c29c9167533653055be7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/nWZws3S6FchdsMZqki6TzQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTU5NA--/https://media.zenfs.com/en/globenewswire.com/ec2fc080a7b8c29c9167533653055be7","width":212,"height":300}},"lazy":false},{"type":"text","content":"--Veteran global investment leader joins neurotechnology company advancing AI-enabled brain health platforms--","length":110,"tagName":"p"},{"type":"text","content":"BALTIMORE, March 20, 2026 (GLOBE NEWSWIRE) -- Longeviti Neuro Solutions, a neurotechnology company developing advanced implantable and AI-enabled solutions for neurological health including the ClearFit AI™, the first Acoustic Brain Interface (ABI)™, today announced the appointment of Robert W. Sharps, Chief Executive Officer and President of T. Rowe Price Group, Inc. (NASDAQ: TROW), to its Board of Directors.","length":413,"tagName":"p"},{"type":"text","content":"Sharps brings three decades of leadership experience in global asset management, capital markets, corporate governance, and strategic growth. As CEO and the Chairman of the Board of T. Rowe Price, he oversees one of the world’s leading investment firms, managing more than $1.5 trillion in assets for individuals, institutions, and retirement investors worldwide.","length":363,"tagName":"p"},{"type":"image","alt":"Robert Sharps","displaySize":"","headline":null,"caption":"Robert Sharps","className":"","disableSlideshowImg":false,"size":{"original":{"width":576,"height":576,"url":"https://media.zenfs.com/en/globenewswire.com/a3a0500cde4487e1873f4eb75b1bdf1c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fVfpd7VdNybt8X.8G4Y90Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MA--/https://media.zenfs.com/en/globenewswire.com/a3a0500cde4487e1873f4eb75b1bdf1c","width":576,"height":576}}},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"“Rob’s leadership and perspective at the intersection of finance, governance, and long-term value creation will be invaluable as Longeviti continues to grow,” said Jesse Christopher, Founder of Longeviti Neuro Solutions. “His exper...